EFSA published a report (7902) on the outcome of the consultation with the Member States on the possible approval of magnesium hydroxide E 528 as a basic substance.
EFSA opened on 23.02.2023 a public consultation on the RAR for flurochloridone.
On 25.10.2022 EFSA published two reports on Benchmark Dose (BMD) Analysis and announced an upcoming workshop on the topic.
On 01.09.2022 EFSA opened a consultation on a draft Guidance Document on water treatment processes
On 22.08.2022 the Commission published a report on the consultation on the revision of the Pollinator Initiative.
EFSA opened on 09.08.2022 a public consultation on the RAR of phosphane.
On 03.08.2022 EFSA opened a consultation on the list of intended studies for disodium phosphonate.
EFSA opened a consultation on an application for setting of MRLs (import tolerance) for mandipropamid in papayas.
EFSA opened a public consultation on the ED-updated RAR for pyraclostrobin.
EFSA opened a consultation on an update of the DAR for clove oil
EFSA opened on 18.07.2022 a public consultation on the Risk Assessment on bees.
EFSA opened on 07.07.2022 a consultation on the updated RAR for 1-methylcyclopropene.
On 07.07.2022 EFSA opened a public consultation on the updated RAR for metrafenone.
EFSA opened on 05.07.2022 a public consultation on the updated RAR for mepanipyrim.
EFSA opened a 2-month consultation on the updated RAR for dichlorprop-P.
EFSA opened a consultation on the updated RAR for the AIR 3.4 substance ziram.
EFSA opened a public consultation on the updated RAR for metconazole.
EFSA opened on 20.06.2022 a public consultation on the assessment of ED properties of mecoprop-P and mecoprop-P ethyl heptyl.
EFSA opened a public consultation on the DAR, and ECHA on the CLH report for the new active substance bixlozone.
EFSA opened on 31.05.2022 a public consultation on the ED properties of flufenacet.